Oxurion NV
€0.29
44
+€0+0.52% 今天
統計
當日最高
0.29
當日最低
0.29
52週最高
-
52週最低
-
成交量
1,881
平均成交量
-
市值
595,758
市盈率
0
股息收益率
-
股息
-
即將到來
收益
30Sep預期
預期每股收益
N/A
實際每股收益
N/A
人們還關注
此列表基於在 Stock Events 上關注 OXUR.BR 的人的關注列表。這不是投資建議。
競爭者
這個列表是基於最近市場事件的分析。這不是投資建議。
Regeneron Pharmaceuticals
REGN
市值130.59B
Novartis
NVS
市值244.75B
Roche
RHHBY
市值272.83B
Bausch Health Companies
BHC
市值2.18B
Abbvie
ABBV
市值346.75B
Biogen
BIIB
市值29.83B
The Nightview Fund NITE
NITE
市值20.8M
Adverum Biotechnologies
ADVM
市值144.36M
關於
Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness. It focuses on developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic atrophy and age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.
Show more...
首席執行官
Mr. Pascal Ghoson
員工
20
國家
BE
ISIN
BE0974487192